Increased masked hypertension prevalence in patients with polycystic ovary syndrome (PCOS)

References

• Barthelmess EK, Naz RK. Polycystic ovary syndrome: current status and future perspective. Elite Front Biosci. 2014;6:104–19.
   PubMedGoogle Scholar
• Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod [Internet]. 2016 ;31(12):2841–55. [cited Apr 2020]. Available from http://www.ncbi.nlm.nih.gov/pubmed/27664216.
   PubMed Web of Science ®Google Scholar
• Cooney LG, Dokras A. Beyond fertility: polycystic ovary syndrome and long-term health [Internet]. Fertil Steril. Elsevier Inc.. 2018; 110(5): 794–809. [cited 2020 Apr 14]. Available from. http://www.ncbi.nlm.nih.gov/pubmed/30316414.
   PubMed Web of Science ®Google Scholar
• Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106(1):6–15. Elsevier Inc.. doi:10.1016/j.fertnstert.2016.05.003.
   PubMed Web of Science ®Google Scholar
• Ortiz-Flores AE, Luque-Ramírez M, Escobar-Morreale HF. Polycystic ovary syndrome in adult women. Med Clin (Barc). 2019;152: 450–57. Ediciones Doyma, S.L.. doi:10.1016/j.medcli.2018.11.019.
   PubMed Web of Science ®Google Scholar
• Behboudi-Gandevani S, Ramezani Tehrani F, Hosseinpanah F, Khalili D, Cheraghi L, Kazemijaliseh H, Azizi F, et al. Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study. Fertil Steril [Internet]. 2018 Dec 1 ;110(7):1377–86. [cited 2020 Apr 14]. Available from]. ; ():. http://www.ncbi.nlm.nih.gov/pubmed/30503137.
   PubMed Web of Science ®Google Scholar
• Welt CK, Carmina E.Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause. J Clin Endocrinol Metab. 2013;98(12):4629–38.doi:10.1210/jc.2013-2375.
   PubMed Web of Science ®Google Scholar
• Cho LW, Randeva HS, Atkin SL.Cardiometabolic aspects of polycystic ovarian syndrome. Vasc Health Risk Manag. 2007;3(1):55–63.
   PubMedGoogle Scholar
• Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013 Dec 18;6(1):1–13. doi: 10.2147/CLEP.S37559.
   PubMedGoogle Scholar
• Moran LJ, Misso ML, Wild RA, Norman RJ.Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod Update. 2010;16(4):347–63.doi:10.1093/humupd/dmq001.
   PubMed Web of Science ®Google Scholar
• Behboudi-Gandevani S, Amiri M, Bidhendi Yarandi R, Noroozzadeh M, Farahmand M, Rostami Dovom M, Ramezani Tehrani F, et al. The risk of metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis. Clin Endocrinol (Oxf). 2018;88(2):169–84. Blackwell Publishing Ltd. doi:10.1111/cen.13477.
   PubMed Web of Science ®Google Scholar
• Fauser BCJM, Bouchard P.Uncertainty remains in women with PCOS regarding the increased incidence of cardiovascular disease later in life, despite the indisputable presence of multiple cardiovascular risk factors at a young age. J Clin Endocrinol Metab. 2011;96(12):3675–77.doi:10.1210/jc.2011-2935.
   PubMed Web of Science ®Google Scholar
• Shaw LJ, Merz CNB, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, Kelsey SF, Kip KE, Cooper-Dehoff RM, Johnson BD, et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the national institutes of health - National heart, lung, and blood institute sponsored women’s ischemia syndrome evaluation. J Clin Endocrinol Metab. 2008;93(4):1276–84.doi:10.1210/jc.2007-0425.
   PubMed Web of Science ®Google Scholar
• Pierdomenico SD, Pierdomenico AM, Coccina F, Clement DL, De Buyzere ML, De Bacquer DA, Ben-Dov IZ, Vongpatanasin W, Banegas JR, Ruilope LM, et al. Prognostic value of masked uncontrolled hypertension systematic review and meta-analysis. Hypertension. 2018;72(4):862–69.doi:10.1161/HYPERTENSIONAHA.118.11499.
   PubMed Web of Science ®Google Scholar
• Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, et al. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25(6):1105–87.doi:10.1097/HJH.0b013e3281fc975a.
   PubMed Web of Science ®Google Scholar
• Luque-Ramírez M, Álvarez-Blasco F, Mendieta-Azcona C, Botella-Carretero JI, Escobar-Morreale HF.Obesity is the major determinant of the abnormalities in blood pressure found in young women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92(6):2141–48.doi:10.1210/jc.2007-0190.
   PubMed Web of Science ®Google Scholar
• Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM.Dietary approaches to prevent and treat hypertension: A scientific statement from the American heart association. Hypertension. 2006;47(2):296–308.doi:10.1161/01.HYP.0000202568.01167.B6.
   PubMed Web of Science ®Google Scholar
• DeUgarte CM, Bartolucci AA, Azziz R.Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril. 2005;83(5):1454–60.doi:10.1016/j.fertnstert.2004.11.070.
   PubMed Web of Science ®Google Scholar
• Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ, Andersen M, Azziz R, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018 Aug 1;110(3):364–79. doi:10.1016/j.fertnstert.2018.05.004.
   PubMed Web of Science ®Google Scholar
• Sachdeva G, Gainder S, Suri V, Sachdeva N, Chopra S.Comparison of the different PCOS phenotypes based on clinical metabolic, and hormonal profile, and their response to clomiphene. Indian J Endocrinol Metab. 2019;23(3):326.doi:10.4103/ijem.IJEM_30_19.
   PubMedGoogle Scholar